Emivirine

This classification denotes a reverse transcriptase inhibitor with the molecular formula C17H22N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X87G8IX72O, chemically known as 2,4(1h,3h)-pyrimidinedione, 1-(ethoxymethyl)-5-(1-methylethyl)-6-(phenylmethyl)- but generally known as emivirine, which bears US NIH Compound Identifier 65013. European Medicines Agency schedules Emivirine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01880MIG. The term EMIVIRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 3, 2000, List 44). Most nations schedule emivirine under HS 29335995 and SITC 51576. As of Q4 2014, EMIVIRINE remains the US FDA Preferred Term for this commodity. Emivirine bears US NLM identifiers UMLS ID C0248121 and NCI Concept Code C73147. SMILES: O(Cn1c(c(C(C)C)c(=O)[nH]c1=O)Cc1ccccc1)CC.